FDA Inspection 1068216 — Starpharma Pty Ltd

Starpharma Pty Ltd — FEI 3011618913

The FDA completed an inspection of Starpharma Pty Ltd on September 28, 2018 in Abbotsford. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 28, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Abbotsford (Australia)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
748221 CFR 312.50General responsibilities of sponsors
750721 CFR 312.52(a)Transfer of obligations